X4 Pharmaceuticals, Inc. - Common Stock (NQ:XFOR)

2.770 -0.130 (-4.48%)

Delayed Quote Updated: 4:00 PM EDT, Oct 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about X4 Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

August 10, 2023

Via Benzinga

Why Krispy Kreme Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

August 10, 2023

Gainers Edible Garden AG Incorporated (NASDAQ: EDBL) shares jumped 58% to $1.88 after the company reported better-than-expected second-quarter financial results.

Via Benzinga

Undervalued Stocks to Watch After X4 Pharma (NASDAQ:XFOR) News: KAVL, HNRC, AYRO, VVPR

May 18, 2023

Via AB Newswire

What 5 Analyst Ratings Have To Say About X4 Pharmaceuticals ↗

May 05, 2023

Via Benzinga

X4 Pharmaceuticals: Q1 Earnings Insights ↗

May 04, 2023

Via Benzinga

Earnings Scheduled For August 10, 2023 ↗

August 10, 2023

Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million.

Via Benzinga

A Preview Of X4 Pharmaceuticals's Earnings ↗

May 03, 2023

Via Benzinga

Oracle And Other Big Stocks Moving Higher In Tuesday's Pre-Market Session ↗

June 13, 2023

U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. SunCar Technology Group Inc. (NASDAQ: SDA) shares jumped 31.2% to $22.13...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

May 17, 2023

Via Benzinga

X4 Pharma Highlights 'Significant Reduction' Rate In Severity, Duration Of Infections ↗

May 17, 2023

X4 Pharmaceuticals Inc (NASDAQ: XFOR) highlighted new data from a Phase 3 clinical trial of once-daily, oral mavorixafor in

Via Benzinga

Earnings Scheduled For May 4, 2023 ↗

May 04, 2023

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is estimated to report quarterly loss at $1.83 per share on revenue of $104.21 million.

Via Benzinga

A Preview Of X4 Pharmaceuticals's Earnings ↗

March 20, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

April 12, 2023

Via Benzinga

Why Panbela Therapeutics Shares Are Trading Higher By Around 25%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

April 12, 2023

Gainers TESSCO Technologies Incorporated (NASDAQ: TESS) shares jumped 86.8% to $8.78 as it agreed to be acquired by entities affiliated with Lee Equity Partners and Twin Point Capital for $9.00 in...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

March 28, 2023

We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Tuesday!

Via InvestorPlace

Earnings Scheduled For March 21, 2023 ↗

March 21, 2023

Companies Reporting Before The Bell • LumiraDx (NASDAQ:LMDX) is projected to report quarterly loss at $0.20 per share on revenue of $41.75 million.

Via Benzinga

Roku Has 26% Of Cash With SVB Financial, Deposit Recovery Uncertain — 27 Other Companies With Ties To Collapsed Bank ↗

March 11, 2023

The collapse of SVB Financial Group (NASDAQ: SIVB) could have a ripple effect on the technology and biotech industries, the two largest sectors that had deposits and financial relationships with the...

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

February 06, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

January 11, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 22, 2022 ↗

December 22, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

December 16, 2022

During Friday's trading, 293 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

December 19, 2022

On Monday, 297 companies reached new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

December 07, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 12, 2022 ↗

December 12, 2022

Via Benzinga

Why iBio Shares Are Trading Lower By Around 48%; Here Are 23 Stocks Moving Premarket ↗

December 07, 2022

Gainers TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares rose 71.3% to $0.7190 in pre-market trading after the company reported withdrawal of registration statement.

Via Benzinga

Why Prometheus Biosciences Shares Are Trading Higher By Over 184%? Here Are 55 Stocks Moving In Wednesday's Mid-Day Session ↗

December 07, 2022

Gainers Prometheus Biosciences, Inc. (NASDAQ: RXDX) shares jumped 184.2% to $102.49 after the company announced results for PRA023 in both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a studies. ARTEMIS-UC...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

December 07, 2022

It's time for another dive into the biggest pre-market stock movers as we check out the latest news traders need to know about on Wednesday!

Via InvestorPlace

Why Leslie's Shares Are Trading Lower By Over 9%? Here Are 60 Stocks Moving In Wednesday's Mid-Day Session ↗

November 30, 2022

Gainers Biophytis S.A. (NASDAQ: BPTS) shares jumped 114% to $0.7496. Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) rose 74.1% to $0.2115.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 30, 2022

Via Benzinga

X4 Pharmaceuticals Shares Tumble After Phase 3 Data From Rare Immune Deficiency Candidate ↗

November 30, 2022

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.